Quatrx Pharmaceuticals, a developer of drugs in the endocrine, metabolic and cardiovascular therapeutic areas, withdrew the application for its IPO on Friday. Banc of America and Cowen & Co. were set to be the joint book runners for the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
